Tailored Screening, Brief Intervention, and Referral to Treatment for Medical Int
量身定制的筛查、简短的干预以及转诊至医疗机构的治疗
基本信息
- 批准号:9094247
- 负责人:
- 金额:$ 17.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAdministratorAdmission activityAdult Respiratory Distress SyndromeAdvisory CommitteesAdvocateAlcohol consumptionAlcoholsAmericanAreaBenchmarkingCaringCharacteristicsClinicalClinical InvestigatorClinical SciencesClinical TrialsColoradoComorbidityCoupledCritical CareCritical IllnessDataDevelopmentEducational ActivitiesEducational CurriculumEffectivenessEmpirical ResearchEnsureEnvironmentEvidence based interventionExtramural ActivitiesFamilyFeedbackFocus GroupsFriendsFutureGoalsGuidelinesHealthHealth PersonnelHealth ServicesHealthcareHealthcare SystemsHigh PrevalenceHospitalsImpaired cognitionInstitutesIntensive Care UnitsInterventionInterviewKnowledgeLeadLearningLeftLifeLiteratureMechanical ventilationMedicalMedicineMentorsMethodsMorbidity - disease rateNational Institute on Alcohol Abuse and AlcoholismOutcomePatientsPositioning AttributeProcessProviderPsychiatryRandomized Controlled TrialsRecommendationRecoveryResearchResearch PersonnelRisk FactorsRoleSentinelSmall Business Innovation Research GrantStructureSurvivorsSystemTestingTimeTraining ProgramsUnited StatesUniversitiesWorkaddictionalcohol misusealcohol related consequencesalcohol related problemalcohol researchalcohol use disorderbasebehavioral outcomecostdesigndrinking behaviorefficacy testingexperienceinterdisciplinary approachinterestloved onesmeetingsmortalitymultidisciplinarynovelpatient populationprogramsprospectivepsychosocialscreening and brief interventionscreening, brief intervention, referral, and treatmentskillstheoriestool
项目摘要
DESCRIPTION (provided by applicant): Unhealthy alcohol use is present in up to 1.4 million survivors of critical illness in the U.S. each year. A severe acute illness requiring admission to medical intensive care unit (MICU) has been advocated as a "teachable moment" where appropriate interventions may lead to decreased morbidity related to alcohol. Although screening, brief intervention, and referral to treatment (SBIRT) has been extensively studied in the healthcare setting, prior studies do not address unique aspects of MICU survivors including a high prevalence of alcohol use disorders, reversible cognitive dysfunction, psychiatric co morbidities, and intimate involvement of family and loved ones in daily care and discharge planning. This proposal outlines a 5-year training program that will adapt and pilot SBIRT for MICU survivors and ultimately develop Dr. Brendan Clark into an independent academic clinical investigator. An integrated curriculum will build a tailored SBIRT system for MICU survivors and provide Dr. Clark with the necessary tools to be a leader in alcohol health services and critical care research. This program will consist of formal mentoring from four internationally renowned local experts in addition to coursework in clinical sciences and addiction. A multidisciplinary team will form an internal advisory committee to ensure that the goals and benchmarks of the proposal will be met. An external advisor whose expertise extends beyond that found at the University of Colorado Denver will provide feedback and input relevant to Dr. Clark's short and long-term goals. This structured curriculum will help Dr. Clark gain expertise in qualitative studies, learn how to design and conduct a randomized controlled trial, and develop knowledge in addiction psychiatry focusing on psychosocial aspects of addiction. The formal curriculum will coincide with practical experience gained through conducting the first prospective mixed methods study of MICU survivors with unhealthy alcohol use. Using a qualitative approach to engage important stakeholders including patients, friends/family, and healthcare providers/hospital systems, the proposed study will build on preliminary data to adapt SBIRT for MICU survivors. Because a high proportion of MICU survivors with unhealthy alcohol use have an AUD, this adapted SBIRT will focus on refining referral to treatment by developing a feasible role for a patient navigator. Subsequently, the feasibility and acceptability of this tailored SBIR system will be assessed in a pilot randomized controlled trial. The results of the proposed studies will tailor SBIRT for MICU survivors and leave Dr. Clark and the study team positioned to conduct a definitive multicenter clinical trial. An SBIRT system tailored to the needs of MICU survivors with unhealthy alcohol use would bridge the gap between treatment need and treatment utilization for a large population of patients at a time when they are uniquely motivated
to change.
描述(由申请人提供):在美国,每年有多达 140 万危重疾病幸存者存在不健康饮酒情况。需要入住医疗重症监护病房(MICU)的严重急性疾病被提倡为“教育时刻”,适当的干预措施可能会降低与酒精相关的发病率。尽管筛查、短暂干预和转诊治疗 (SBIRT) 已在医疗保健环境中进行了广泛研究,但先前的研究并未解决 MICU 幸存者的独特方面,包括酒精使用障碍、可逆性认知功能障碍、精神并发症和精神疾病的高患病率。家人和亲人密切参与日常护理和出院计划。该提案概述了一项为期 5 年的培训计划,该计划将为 MICU 幸存者调整和试点 SBIRT,并最终将 Brendan Clark 博士培养成为一名独立的学术临床研究者。 综合课程将为 MICU 幸存者构建量身定制的 SBIRT 系统,并为 Clark 博士提供成为酒精健康服务和重症监护研究领导者所需的工具。除了临床科学和成瘾方面的课程外,该计划还将包括四位国际知名当地专家的正式指导。多学科团队将组建一个内部咨询委员会,以确保提案的目标和基准得到满足。一名外部顾问的专业知识超出了科罗拉多大学丹佛分校的专业知识,他将提供与克拉克博士的短期和长期目标相关的反馈和意见。这种结构化课程将帮助克拉克博士获得定性研究方面的专业知识,学习如何设计和进行随机对照试验,并发展专注于成瘾心理社会方面的成瘾精神病学知识。 正式课程将与通过对不健康饮酒的 MICU 幸存者进行首次前瞻性混合方法研究所获得的实践经验相一致。拟议的研究将采用定性方法吸引重要利益相关者(包括患者、朋友/家人和医疗保健提供者/医院系统)的参与,以初步数据为基础,使 SBIRT 适应 MICU 幸存者。由于大部分患有不健康饮酒的 MICU 幸存者都有 AUD,因此经过调整的 SBIRT 将重点通过为患者导航员开发一个可行的角色来完善转诊治疗。随后,该定制 SBIR 系统的可行性和可接受性将在试点随机对照试验中进行评估。 拟议研究的结果将为 MICU 幸存者量身定制 SBIRT,并使 Clark 博士和研究团队能够进行最终的多中心临床试验。针对不健康饮酒的 MICU 幸存者的需求量身定制的 SBIRT 系统将在大量患者有独特动机时弥合治疗需求和治疗利用之间的差距
改变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brendan James Clark其他文献
Brendan James Clark的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brendan James Clark', 18)}}的其他基金
Tailored Screening, Brief Intervention, and Referral to Treatment for Medical Int
量身定制的筛查、简短的干预以及转诊至医疗机构的治疗
- 批准号:
8699925 - 财政年份:2014
- 资助金额:
$ 17.94万 - 项目类别:
Tailored Screening, Brief Intervention, and Referral to Treatment for Medical Int
量身定制的筛查、简短的干预以及转诊至医疗机构的治疗
- 批准号:
9303854 - 财政年份:2014
- 资助金额:
$ 17.94万 - 项目类别:
相似国自然基金
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活性脂质Arlm-1介导的自噬流阻滞在儿童T细胞急性淋巴细胞白血病化疗耐药逆转中的作用机制研究
- 批准号:82300182
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 17.94万 - 项目类别:
Identification of gene variants mediating the behavioral and physiological response to THC
鉴定介导 THC 行为和生理反应的基因变异
- 批准号:
10660808 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Determining medications associated with drug-induced pancreatic injury through novel pharmacoepidemiology techniques that assess causation
通过评估因果关系的新型药物流行病学技术确定与药物引起的胰腺损伤相关的药物
- 批准号:
10638247 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer
分级姑息治疗:基于人群的护理提供模式,以满足不断变化的患者需求,并为社区心力衰竭或癌症患者提供姑息治疗服务
- 批准号:
10880994 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别: